HYPO G

This brand name is authorized in Nigeria.

Active ingredients

The drug HYPO G contains one active pharmaceutical ingredient (API):

1	Glibenclamide UNII SX6K58TVWC - GLYBURIDE
	Glibenclamide, a second-generation, short half-life sulphonylurea, is a hypoglycaemic agent that reduces blood-glucose by stimulating insulin release by the pancreas. Sulphonylureas act on pancreatic beta-cells by inhibiting ATP-sensitive potassium channels.
	Read more about Glibenclamide

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-6476	Tablet	Hypo G 5 mg Tablet TAB 5 mg 10 x 10's (in PVC-Alu blister packs)	Tablet A white colored round shape flat uncoated tablets, having "CHCL" on one side and symbol of "CHANRAI" on other side of the tablets 71 RNW-PP-213252 HYPOG 5MG TABLET GLIBENCLAMIDE TABLET B.P. 5MG Active: Glibenclamide BP Excipients: Pregelatinized maize starch, Lactose Monohydrate, Povidone k-30, Magnesium Stearate, Purified water B4-6476 Drugs Imported Products 10x10 Prescription Only Medicine (POM) 5/25/2021 CHANRAI HEALTHCARE LIMITED, OSHODI APAPA EXPRESSWAY, ISOLO LAGOS 7019980312 sp@chanraihealthcare.com BHARAT PARENTERALS LIMITED INDIA, SURVEY NO. 144 & 146, JAROD SAMLAYA ROAD, VILL HARIPURA, TA-SAVLI, BARODA- 391520 GUJARAT, India	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BB01	Glibenclamide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives
Discover more medicines within A10BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-6476